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Summary
Our laboratory has developed twelve human breast cancer cell lines from primary and metastatic sites. In this report
we demonstrate that eight of eight breast cancer cell lines examined exhibit constitutively tyrosine phosphorylated
and enzymatically active endogenous pp125f ak when grown in monolayer. The activation status of pp125f ak in
breast cancer cells in monolayer is significantly elevated over that exhibited by normal mammary epithelial cells
cultured under the same conditions. Constitutive activation of pp125f ak is the only characteristic so far studied
that all of these breast cancer cell lines have in common. In contrast to HBC cells, tyrosine phosphorylation of
pp125f ak in HME cells was low or absent in monolayer culture but was induced to high levels by culturing the cells
in Matrigel. Thus tyrosine phosphorylation and activation of pp125f ak is a regulated process in normal mammary
epithelial cells, but is constitutive in breast cancer cells. Finally, analysis of the ability of normal human mammary
epithelial cells and breast cancer cell lines to grow under anchorage-independent conditions indicated that normal
human mammary epithelial cells rapidly and uniformly lost viability when not substrate-attached, whereas all of
the breast cancer cell lines survived for a 3-week culture period. Furthermore, a subset of the breast cancer cell lines
grew to form large colonies under anchorage-independent conditions. Interestingly, pp125f ak activation decreased
dramatically in HBC cells cultured for two weeks in suspension, suggesting that activation of this kinase is not
necessary for long-term growth under anchorage-independent conditions. These results suggest that constitutive
activation of pp125f ak results in preferential survival of human breast cancer cells under anchorage-independent
conditions but that activation of pp125f ak is not the sole mediator of anchorage-independent colony formation.
Introduction
Attachment of mammary epithelial cells to extracel-
lular matrix (ECM) is essential for normal tissue
homeostasis. Signals sent from extracellular matrix re-
ceptors on the cell surface take part in the regulation of
cell growth, differentiation, morphogenesis, and sur-
vival [1]. Attachment of human mammary epithelial
(HME) cells occurs, in part, through integrins, cell sur-
face receptors composed of heterodimers of one alpha
and one beta subunit [2]. The specific combination of
alpha and beta subunits expressed on the surface of cells
directs their substrate specificity for attachment [1].
HME cells, when placed in a laminin-rich basement
membrane, undergo growth and morphogenesis, and
develop acinar structures similar to mammary ducts.
By contrast, human breast cancer (HBC) cells form
amorphous colonies when grown in the same matrix.
Recently, Howlett, et al. [3] demonstrated that HME
cells cultured inMatrigel in the presence of anti-b1-
integrin antibodies undergo apoptosis, whereas breast
cancer cells do not. These observations are similar
to those made earlier by Frisch and Francis [4] with
HT1080 cells and MDCK cells, and by Meredith,
et al. with HME cells [5]. These data suggest that
normal human mammary epithelial cells require sig-
nals derived from attachment to extracellular matrix to
survive in three-dimensional culture, and that human
breast cancer cells have acquired independence of these
signals.
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In 1992, Schaller, et al. [6] identified a protein
of about 125 kDa as a putative substrate of acti-
vated pp60c−src. This membrane-associated tyrosine
kinase was termed focal adhesion kinase, or FAK.
About the same time as Schaller, et al. identified
pp125f ak, it was demonstrated that signaling through
the fibronectin/b1-integrin receptor system caused an
increase in tyrosine phosphorylation of an approxi-
mately 120 kDa protein [7]. It was later shown by Guan
and Shalloway [8] that the 120 kDa protein activated by
the fibronectin/b1-integrin interaction was pp125f ak.
In fibroblasts, thefak protein is localized to focal ad-
hesions [6, 9] by binding to theb1-integrin [9]. The
precise intracellular localization of pp125f ak in HME
cells has still not been clearly defined.
Since blocking b1-integrin-mediated signaling
triggers apoptosis in mammary epithelial cells, the
activation state of pp125f ak may play a role in the
regulation of programmed cell death. Furthermore,
dysregulated pp125f ak activation may protect HBC
cells against apoptosis, and in that way be partly re-
sponsible for certain transformed properties of HBC
cells. Evidence in support of this hypothesis came from
Weiner, et al. [10], who examined the expression of
fakmRNA in breast cancer cells and normal mammary
cells in vivo. They found that 9 of 11 primary breast
cancers contained elevated levels offakmRNA as com-
pared to benign breast tissue, and all four metastatic
tumors studied had high levels offakexpression. Later,
Owens, et al. [11] demonstrated that 88% of invasive
and metastatic breast tumors studied had significantly
elevated pp125f ak levels compared to normal tissue
from the same patient. These data suggest thatfak
expression plays a role in breast cancer development
and invasive potential.
Our laboratory has recently established twelve
HBC cell lines from various stages of breast cancer.
In the present studies, several of these lines were ex-
amined for expression and activation of pp125f ak. The
data presented here indicate that a phenotype common
to all of these breast cancer cell lines is the constitutive
activation of pp125f ak and the ability to survive in
a matrix-independent manner. This is in contrast to
both MCF-10A cells and primary cultures of normal
HME cells which express pp125f ak protein in mono-
layer but which require growth inMatrigel for tyrosine
phosphorylation and activation of this kinase. Thus,
constitutive activation of pp125f ak is a common fea-
ture of human breast cancer cell lines and may underlie




The base medium for MCF-10A, SUM-44PE, SUM-
102PT, and SUM-190PT cells was Ham’s F12
medium supplemented with 0.1% bovine serum al-
bumin, 0.5mg/ml funigzone, 5mg/ml gentamycin,
5 mM ethanolamine, 10 mM HEPES, 5mg/ml trans-
ferrin, 10mM T3, 50mM selenium, 5mg/ml insulin,
and 1mg/ml hydrocortisone. MCF-10A and SUM-
102PT cell medium was further supplemented with
10 ng/ml EGF. The base medium for HME, SUM-
52PE, SUM-149PT, SUM-159PT, SUM-185PE, and
SUM-1315MO2 was Ham’s F12 supplemented with
5% fetal bovine serum (FBS), 0.5mg/ml fungizone,
5mg/ml gentamycin, and 5mg/ml insulin. SUM-
52PE, SUM-149PT, SUM-159PT, and SUM-185PE
cell medium was further supplemented with 1mg/ml
hydrocortisone. HME cell medium was further supple-
mented with 1mg/ml hydrocortisone, 10 ng/ml EGF,
and 100mg/ml cholera toxin. SUM-1315MO2 cell
medium was further supplemented with 10 ng/ml EGF
and did not contain hydrocortisone. All cell culture
reagents were obtained from Sigma Chemical Co. (St.
Louis, MO).
HME cells were grown on collagen-coated tissue
culture plates or inMatrigel (Collaborative Biomedical
Products, Bedford, MA). Cells grown inMatrigelwere
plated in a 50/50 (v/v) mixture ofMatrigel and HME
medium. Cells were grown for two weeks prior to use
for further experiments.
Detailed descriptions of all of the SUM cell lines
can be found at http://p53.cancer.med.umich.edu/clines
/ekb/ethier.html on the world wide web.
Immunoprecipitations and protein blots
Cells were lysed in a buffer consisting of 20 mM
Tris–HCl, pH 8.0, 137 mM NaCl, 1% Nonidet P-40,
10% glycerol, 1 mM Na3VO4, 1 mM PMSF, 2mg/ml
aprotinin, and 50mg/ml leupeptin. Protein concentra-
tions were equalized using the Lowry method [12].
Equal amounts of protein were either loaded on 7.5%
SDS-PAGE or immunoprecipitated witha-pp125f ak
(Catalog no. F15020, Transduction Labs, Lexington,
KY). Antibody was incubated with lysate for 1 h at 4◦C.
The immune complex was bound to protein A/G beads
(Catalog no. IP10X, Calbiochem, Cambridge, MA)
for 40 min 4◦C. Immunoprecipitates were washed two
times with phosphate buffered saline (PBS) containing
1% Triton X-100, two times with PBS containing 0.5%
Triton X-100, and two times with PBS. Læmmeli sam-
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ple buffer [13] was added and the samples were boiled.
Equal amounts were loaded onto 7.5% SDS-PAGE.
Separated proteins were blotted to PVDF membrane
and probed with eithera-pp125f ak ora-Ptyr4G10(Cat-
alog no. 05-321, Upstate Biotechnology, Inc., Lake
Placid, NY). These experiments were performed at
least twice.
Kinase assays
a-pp125f ak immunoprecipitates were washed twice in
lysis buffer and once in kinase assay buffer (50 mM
Tris–HCl, pH 7.4, 10 mM MnCl). Immunoprecipitates
were mixed with prewarmed kinase assay buffer con-
taining 20mM ATP, 10mCi g-32P-ATP, and 0.5mg/ml
poly(Glu : Tyr)4:1 (Catalog no. P-0275, Sigma Chem-
ical Co., St. Louis, MO). The reactions were allowed to
proceed for 20 min at 30◦C, stopped with the addition
of Læmmeli sample buffer, and boiled. Reactions were
then separated on 10% SDS-PAGE, blotted to PVDF,
and probed for pp125f ak to be sure each sample had
equivalent amounts of the kinase. Blots were then ex-
posed to film−80◦C for 2 h to 2 days and quantitated
by densitometry. This was repeated twice.
Soft agar assays
Six-well dishes were coated with a 1:1 mix of the ap-
propriate 2× medium for the cell line being studied and
1% Bactoagar. Cells were plated at 1× 103, 1 × 104,
and 1× 105 cells per well in a mixture of appropri-
ate medium and 0.3% Bactoagar. Cells were fed three
times per week for 3 weeks, stained with 500mg/ml p-
iodonitrotetrazolium violet (Catalog no. I-8377, Sigma
Chemical Co., St. Louis, MO) overnight, counted, and
photographed. Each cell line was plated in duplicate
in three separate dilutions. Colonies were counted for
each duplicate of each dilution and averaged together.
This experiment was repeated twice.
Methyl cellulose plating
Six-well dishes were coated with 1:1 mix of the ap-
propriate 2× medium for the cell line being studied
and 1% Bactoagar. Cells were plated at 1× 06 cells
per well in a 1:1 mix of the appropriate 2× medium
for the cell line being studied and 1% methyl cellulose
(Catalog no. M-7027, Sigma Chemical Co., St. Louis,
MO). Cells were fed three times per week for 2 weeks,
retrieved, and replated. This experiment was performed
in duplicate.
Results
Human breast cancer cell lines
Our laboratory has now established 12 human breast
cancer cell lines from primary and metastatic breast
cancer specimens. All of the HBC cell lines established
thus far express luminal cytokeratins, are aneuploid,
and exhibit distinct areas of gene amplification and
gene loss. Descriptions and characterizations of some
of these cell lines, including SUM-44PE, SUM-52PE,
SUM-16LN, SUM-102PT, have been published previ-
ously [14–17]. In addition, data on the SUM-149PT
and SUM-159PT cell lines have been published as part
of a larger study on Stat3 activation in human breast
cancer cells [18]. Finally, genetic analysis of the entire
panel of breast cancer cell lines, which includes both
Southern analysis and comparative genomic hybridiza-
tion studies, have recently been completed (submitted
for publication).
Table 1 lists the current panel of breast cancer cell
lines (the SUM-16LN cell line is no longer available),
Table 1. Molecular characteristics of SUM HBC cell lines
Cell line Oncogene EGFR exp p53 (IHC)
Ampa
SUM-44PEb FGFR-1c − +(c)e
cycD1d
c-mycd
SUM-52PE FGFR-1c − +(c)
FGFR-2c
cycD1d
SUM-102PT none + + + –
SUM-149PT none + + + +(n)
SUM-159PT c-mycd ++ +(n)
SUM-1315MO2 none + +(n)
SUM-185PE none + NE
SUM-190PT erb B-2c + +(n)
cycD1c
SUM-206cwn none + +(n)
SUM-225cwn erb B-2c − NE
c-mycd
SUM-229PE none + + + NE
aOncogenes examined by Southern blot: erbB-2, c-myc, Prad-1,
FGFR-1, 2, 4.
bPT = primary tumor; MO2= mouse xenograft, second trans-
plant generation; PE= pleural effusion; CWN= chest wall
nodule.
cHigh level amplifications detected by Southern blot.
dLow level amplifications (2–3 fold) detected by FISH.
e(c) = cytoplasmic staining;(n) = nuclear staining; NE= not
examined.
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Figure 1. HBC cell lines contain increased pp125f ak tyrosine phosphorylation. Proteins from whole cell lysates were separated on
SDS-PAGE, blotted to PVDF, and probed witha-pp125f ak antibody (a). pp125f ak was immunoprecipitated from control and HBC
cells. Immunoprecipitated proteins were separated on SDS-PAGE, blotted to PVDF, and probed witha-pp125f ak antibody (b) or with
a-Ptyr4G10(c). Relative specific amounts of tyrosine-phosphorylation pp125
f ak are indicated. Relative specific tyrosine-phosphorylation
was determined by quantitation of the western by densitometry, setting the amounts of pp125f ak and of tyrosine phosphorylation relative
to the amount in MCF-10A, then normalizing the amount of phosphotyrosine to the amount of pp125f ak in each lane.
indicates the type of specimen from which each cell
line was derived, and provides a brief summary of the
cellular and molecular characteristics of each cell line.
As can be seen from the table, cell lines with amplifica-
tions of the oncogenes frequently implicated in breast
cancer development, including ERBB-2, Cyclin-D1
(PRAD-1), c-MYC, FGFR-1, and FGFR-2, are present
in this panel. Also, some of these breast cancer cell lines
express high levels of EGFR in the absence of gene am-
plification. One cell line, SUM-44PE, expresses high
levels of estrogen receptor (D. Zajchowski, S. Ethier,
unpublished observations). Finally, these cell lines ex-
hibit a range of p53 phenotypes. Thus, this panel of
human breast cancer cell lines is representative of the
molecular heterogeneity observed in uncultured breast
cancer specimens.
HBC cell lines have increasedpp125f ak activity
Weiner, et al. and Owens, et al. [10, 11] demonstrated
that human breast cancers express elevated levels offak
mRNA and of pp125f ak protein compared to normal
breast tissue. Based on these observations, we sought to
determine if our HBC cell lines express elevated levels
of fak protein compared to normal proliferating HME
cells. At the time this study was initiated, only eight of
the current 11 cell lines had been established and fully
characterized and only those are included in this study.
Western blot analysis of cell lysates obtained from
HBC cell lines, MCF-10A cells, and primary HME
cells demonstrated that all of these cells express sim-
ilar levels of pp125f ak protein (Figures 1a and 3b).
Thus, proliferating HME cells, unlike normal resting
mammary epitheliumin vivo, express significant lev-
els of pp125f ak. To compare the activation status of
pp125f ak in HBC cells to normal HME cells, western
blots of pp125f ak immunoprecipitates were probed
with antiphosphotyrosine antibodies or with anti-fak
antibodies. Figure 1 shows that all of the HBC cell
lines examined had increased levels of tyrosine phos-
phorylated pp125f ak compared to MCF-10A cells. In
order to quantitate the difference in the levels of ty-
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Figure 2. HBC cell lines contain increased pp125f ak activity. pp125f ak was immunoprecipitated from control and HBC cells and
subjected toin vitro kinase assays using poly(Glu:Tyr)4:1 as a substrate. Reaction products were separated on 10% SDS-PAGE and
blotted to PVDF membrane. The blots were probed witha-pp125f ak antibody, to obtain the relative amounts of pp125f ak in each
reaction, then subjected to autoradiography. Both the kinase assay and the anti-fakblot are shown. The relative specific kinase activity is
indicated.
rosine phosphorylated pp125f ak in the different HBC
cell lines to that found in MCF-10A cells, densitometry
analysis was performed comparing the phosphotyro-
sine band in each cell line with that in MCF-10A cells
and then normalizing that result to the overall amount
of pp125f ak that was present in the immunoprecipi-
tate. This analysis yielded the relative specific increase
in tyrosine phosphorylated pp125f ak in each cell line
as compared to MCF–10A cells. The results indicate
that all the breast cancer cell lines examined had ap-
proximately 1.5–2.0 fold increased levels of tyrosine
phosphorylated pp125f ak compared with MCF-10A
cells.
To confirm that pp125f ak enzymatic activity was
higher in HBC cells than in MCF-10A cells,in vitro
kinase assays were performed. In this assay, pp125f ak
immunoprecipitates were tested for their ability to
phosphorylate the artificial substrate poly-glu-tyr. The
results shown in Figure 2 confirm the increased en-
zymatic activity of pp125f ak in HBC cells compared
to MCF-10A controls (Figure 1). Once again, quanti-
tation and normalization of the kinase assay demon-
strated a two-fold increase in pp125f ak kinase activity
in HBC cells compared to MCF-10A cells.
To examine the expression and activation of
pp125f ak in non-immortalized HME cells and to de-
termine if pp125f ak present in these cells could be
activated by stimulation with extracellular matrix,
primary cultures of reduction mammoplasty derived
HME cells were cultured either in monolayer or in
the basement membrane matrixMatrigel. The cells
were cultured using a medium that we previously
showed supports the growth of normal HME cells
of the luminal lineage [14]. HME cells grown in
monolayer exhibited a characteristic epithelial cell cob-
blestone appearance, whereas the same cells grown
in Matrigel grew into three-dimensional structures ex-
hibiting ductal branching and formation of acini (Fig-
ure 3a). Antiphosphotyrosine-probed Western blots of
pp125f ak immunoprecipitates derived from HME cells
cultured under both conditions revealed a dramatic in-
crease in levels of tyrosine-phosphoryplated pp125f ak
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Figure 3. (a) HME cells exhibit differentiated morphology when grown in basement membrane. HME cells were grown either on
collagen-coated tissue culture plates or in the laminin-rich basement membraneMatrigel. (b) HME cells grown in basement membrane
contain higher levels of pp125f ak activity than HME cells grown in two-dimensional culture. pp125f ak was immunoprecipitated from
cell lysates of HME cells grown on tissue culture plates or inMatrigel, separated on SDS-PAGE, blotted to PVDF, and probed with
a-Ptyr4G10antibody. Whole cell lysates from the same cells before immunoprecipitation were separated on 7.5% SDS-PAGE and probed
with α-pp125f ak to show that the same amount of pp125f ak was present under both growth conditions.
in cells grown inMatrigelas compared to cells grown in
monolayer culture (Figure 3b). In fact, tyrosine phos-
phorylated pp125f ak was undetectable in HME cells
grown in monolayer. Thus, in HME cells, pp125f ak
tyrosine phosphorylation is strictly the result of inter-
action with the basement membrane proteins or other
Matrigel-associated factors, in a manner that does not
occur in monolayer.
In summary, these experiments demonstrated that
pp125f ak is expressed in proliferating normal and
neoplastic breast epithelial cells. However, tyrosine
phosphorylation and enzymatic activity of this kinase
is undetectable in primary HME cells in monolayer
culture, is slightly elevated in MCF-10A cells, and
is activated to higher levels still in all HBC cell lines
examined.
HBC cells containing activatedpp125f ak survive
under anchorage-independent conditions
A hallmark of cellular transformation is the ability of
cells to produce colonies in an anchorage-independent
manner [19]. In addition, previous work has implicated
pp125f ak in the ability of epithelial cells to survive
and grow in soft agar [20]. In order to assess the
ability of our HBC cell lines to grow under anchorage-
independent conditions, several of the cell lines, as well
as HME cells and MCF-10A cells, were grown for 3
weeks in soft agar suspension. The results shown in
Figures 4 and 5 indicate that some of the HBC cells
formed large progressively growing colonies in agar,
Figure 4. Anchorage-independent growth assay of HBC cell lines
and normal HME cells. Control cell lines and HBC cell lines were
grown in 0.3% agar for 3 weeks, stained with the viable stain
p-iodonitrotetrazolium violet, and colonies greater than 2 mm
were counted. Each cell line was plated in duplicate in three
separate dilutions. Colonies were counted for each duplicate of
each dilution and averaged together.
whereas cells from other lines formed small colonies
or remained as single cells. By contrast, HME and
MCF-10A cells not only did not form colonies in agar,
but after the 3 week culture period, no viable cells
pp125f ak activation in human breast cancer179
Figure 5. Growth of HME and HBC cells in soft agar. Control cell lines and HBC cell lines were grown in 0.3% agar for 3 weeks, stained
with the viable stainr-iodonitrotetrazolium violet. Each cell line was plated in duplicate in three separate dilutions.
Figure 6. The HBC cells that survived in small colonies in soft agar are viable. MCF-10A, SUM-149PT, and HBC cells that formed
small colonies in soft agar were plated in methyl cellulose, retrieved, and replated. Representative replatings are shown.
could be detected in these culture wells. Comparison
of the activation status of pp125f ak with the ability
of a particular cell line to form large colonies in soft
agar did not demonstrate a direct correlation between
these two phenotypes. However, the observation that all
HBC cells appeared to survive in agar, whereas MCF-
10A and HME cells did not remain viable under these
conditions, suggested that pp125f ak activation plays
a role in matrix-independent survival of HBC cells, if
not growth potential in agar.
To confirm that the HBC cells that only formed
small colonies in soft agar were indeed viable, cells
from these lines were cultured for 2 weeks in sus-
pension culture in methyl cellulose, then retrieved
and replated in monolayer. As controls, MCF-10A
cells, which appeared to lose viability in soft agar,
and SUM-149PT cells, which formed large colonies
in agar, were also grown in methyl cellulose. Over
the first few days in methyl cellulose, MCF-10A cells
formed small aggregates. However, after 2 weeks in
suspension culture, these aggregates did not appear
viable, and retrieving and replating the cells did not
result in any cell attachment. The HBC cells that
formed small colonies in soft agar formed similarly
sized colonies when grown in methyl cellulose. When
these cells were recovered from the suspension culture
and placed in monolayer, they attached and resumed
proliferating. As expected, SUM-149PT cells formed
large colonies in methylcellulose that, when replated,
attached and grew rapidly (Figure 6). These results
indicate that all of the HBC cell lines tested did, indeed,
remain viable under anchorage-independent condi-
tions, whereas MCF-10A and HME cells rapidly lost
viability.
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Figure 7. Suspended HME cells rapidly lose pp125f ak activation whereas suspended HBC cells do not. HME and HBC cells were
plated on tissue culture plastic. One week later, cells were either lysed after trypsinization, or pp125f ak activation was determined by
anti-pp125f ak immunoprecipitation and then anti-phosphotyrosine Western blot. The amount of pp125f ak was determined by probing
identical blots with anti-pp125f ak .
Figure 8. HBC cells maintained in a semi-solid medium lose pp125f ak activation. HBC cells were plated on tissue culture plastic or in
methyl cellulose and maintained for two weeks. Cells were retrieved and lysed. pp125f ak activation was determined by anti-pp125f ak
immunoprecipitation and then anti-phosphotyrosine Western blot. The amount of pp125f ak was determined by probing the same blot
with anti-pp125f ak .
Extended survival and growth of HBC cells in
suspension is independent ofpp125f ak activation
To examine further the role of pp125f ak activation
in anchorage-independent survival and growth of our
HBC cell lines, experiments were carried out to mea-
sure pp125f ak tyrosine phosphorylation in HBC and
MCF-10A cells after being released from monolayer
culture, and after extended growth in methyl cellulose.
The data in Figure 7 show that tyrosine phosphory-
lated pp125f ak was undetectable in MCF-10A cells
and in three of the eight HBC cell lines examined af-
ter the cells had been released from the substratum.
Thus, in MCF-10A and some HBC cells, tyrosine
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phosphorylated pp125f ak is rapidly lost upon release
from substrate. Interestingly, after extended growth of
HBC cells in suspension culture, none of the HBC
cell lines examined exhibited tyrosine phosphorylated
pp125f ak. Thus, regardless of whether HBC cells
grow to form large or small colonies in suspension,
tyrosine phosphorylated pp125f ak was not detected
in these cells after extended growth in suspension
culture.
Taken together, these results suggest that the high
levels of activated pp125f ak detected in lysates of HBC
cells grown in monolayer culture were the result of
interaction of the cells with the substratum in a manner
which does not occur in normal HME cells. These
results also suggest that in these HBC cell lines, the
ability to survive for extended periods of time and
to grow in suspension culture are independent of the
activation status of pp125f ak.
Discussion
The interaction of the extracellular matrix (ECM) with
epithelial cells in influencing cell growth and morpho-
genesis has been studied in both rodent and mammalian
cells for some time. ECM is deposited by the ep-
ithelial cells and stromal fibroblasts [1]. Activation of
specific signaling pathways via interactions of epithe-
lial cell surface molecules with ECM are required for
three-dimensional growth of normal human and rodent
mammary epithelial cells [1]. HME cells grown in
three-dimensional culture in the basement membrane
Matrigel form structures reminiscent of fully differ-
entiated alveoliin vivo. This is in contrast to HME
cells grown on tissue culture plates, which have the
characteristic epithelial cell cobblestone appearance.
Howlett et al. [3] demonstrated the importance of the
b1-integrin signaling pathway for human mammary
epithelial cells grown in three-dimensional culture.
Blockage of b1-integrin’s interactions with the ex-
tracellular matrix using an anti-b1-integrin antibody
caused the cells to undergo apoptosis. In contrast,
HBC cells grown under the same conditions did not
organize into differentiated structures in this basement
membrane matrix and did not undergo apoptosis when
exposed to the anti-b1-integrin antibody.
It is known thatb1-integrin binding to ECM acti-
vates a pathway that results in activation of pp125f ak
[8]. pp125f ak is a cytoplasmic tyrosine kinase [6] that
binds b1-integrin in the cytosol through a sequence
in its carboxy terminus [9]. It was previously shown
in primary uncultured human breast cancers thatfak
mRNA and protein levels are elevated relative to sur-
rounding normal mammary epithelia [10, 11]. This
suggests that expression and activation of pp125f ak is
an important aspect of HBC growth, particularly since
these cells are often not in contact with normal substrate
molecules [21]. The data obtained in our experiments
support this hypothesis. We found that normal HME
cells require interactions with components ofMatrigel
in order to activate endogenous pp125f ak (Figure 4).
By contrast, all of the HBC cell lines examined had
constitutively activated endogenous pp125f ak when
grown in monolayer. The HBC cell lines developed
in our laboratory represent the range of molecular di-
versity seen in clinical breast cancer specimens. Each
of the breast cancer cell lines developed in our lab has
a unique constellation of molecular alterations, and,
until now, no single characteristic has been observed
uniformly in all of the cell lines. The data presented
here indicate that pp125f ak activation is a common
characteristic of these HBC cell lines.
There is suggestive evidence in the literature
that pp125f ak activation is required for anchorage-
independent growth of transformed cells [22]. Our
data indicate that constitutive pp125f ak activation may
be important for survival in the absence of matrix-
derived signals but is not sufficient for formation of
large colonies in soft agar. This interpretation is based
on the observation that HME cells failed to survive
in soft agar (Figures 5 and 7), whereas the HBC cell
lines with activated pp125f ak survived under these
conditions. However, only a subset of the HBC cell
lines formed large colonies in soft agar and none of the
HBC cells maintained high levels of tyrosine phospho-
rylated pp125f ak after extended growth in suspension
culture. Thus, activation of pp125f ak appears not to
be required for anchorage-independent growth of HBC
cells. Rather, the results of our experiments suggest
that the tyrosine phosphorylation and activation of
pp125f ak that we observed in our breast cancer cell
lines is the result of interactions of HBC cells with
the substrate when the cells are in monolayer culture.
Similar activation of pp125f ak did occur in HME cells
in monolayer culture but did occur when the cells were
grown in Matrigel. Thus, aberrant cell substrate in-
teractions that occur in HBC cells but not HME cells
may result in abnormal activation of pp125f ak. The
observation that our HBC cell lines have uniformly
lost expression ofb4-integrins, while maintaining ex-
pression ofb1-integrins (data not shown), suggests the
possibility that alterations in integrin expression under-
lie the abnormal activation of pp125f ak in HBC cells.
Further work will be required to better understand the
relationship between integrin expression and pp125f ak
activation in HBC cells.
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